{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:07:22Z","timestamp":1776038842350,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2145,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1111\/j.1524-4733.2007.00188.x","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T19:06:40Z","timestamp":1179774400000},"page":"348-357","source":"Crossref","is-referenced-by-count":27,"title":["The Cost-Effectiveness of Bisphosphonates in Postmenopausal Women Based on Individual Long-Term Fracture Risks"],"prefix":"10.1016","volume":"10","author":[{"given":"Tjeerd-Peter","family":"van Staa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Geusens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert G.M.","family":"Leufkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1524-4733.2007.00188.x_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(02)09832-X","article-title":"A rational framework for decision making by the National Institute for Clinical Excellence (NICE)","volume":"360","author":"Claxton","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s001980200117","article-title":"Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis","volume":"13","author":"Zethraeus","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib30","series-title":"Alendronate, Etidronate, Risedronate, Raloxifene and Strontium Ranelate for the Primary and Secondary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women","author":"Stevenson","year":"2005"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S8756-3282(02)00813-X","article-title":"Intervention thresholds for osteoporosis","volume":"31","author":"Kanis","year":"2002","journal-title":"Bone"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib50","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","article-title":"The UK general practice research database","volume":"350","author":"Walley","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/qjmed\/hci029","article-title":"A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids","volume":"98","author":"van Staa","year":"2005","journal-title":"QJM"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","article-title":"Assessment of fracture risk","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib80","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S8756-3282(02)00848-7","article-title":"Utility of medical and drug history in fracture risk prediction among men and women","volume":"31","author":"van Staa","year":"2002","journal-title":"Bone"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib90","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1359\/jbmr.2002.17.4.716","article-title":"Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS)","volume":"17","author":"Felsenberg","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3310\/hta6290","article-title":"Treatment of established osteoporosis","volume":"6","author":"Kanis","year":"2002","journal-title":"Health Technol Assess"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib110","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"IX: summary meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/bmj.316.7133.736","article-title":"Variations in population health status: results from a United Kingdom national questionnaire survey","volume":"316","author":"Kind","year":"1998","journal-title":"BMJ"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1586\/14737167.1.1.25","article-title":"Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses","volume":"1","author":"Glick","year":"2001","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib150","series-title":"The Clinical Effectiveness and Cost-Effectiveness of Prevention and Treatment of Osteoporosis","author":"Stevenson","year":"2003"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib160","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1524-4733.2006.00081.x","article-title":"Developing better economic models of osteoporosis: considerations for the calculation of the relative risk of fracture","volume":"9","author":"Black","year":"2006","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00198-004-1623-4","article-title":"Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib200","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1001\/jama.292.23.2890","article-title":"Does this woman have osteoporosis?","volume":"292","author":"Green","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4065\/77.7.629","article-title":"Performance of risk indices for identifying low bone density in postmenopausal women","volume":"77","author":"Geusens","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib220","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S8756-3282(03)00061-9","article-title":"The components of excess mortality after hip fracture","volume":"32","author":"Kanis","year":"2003","journal-title":"Bone"},{"key":"10.1111\/j.1524-4733.2007.00188.x_bib230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985\u20131989","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830151060472X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830151060472X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T07:54:30Z","timestamp":1546847670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830151060472X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S109830151060472X"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00188.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}